Literature DB >> 14304244

OBSERVATIONS ON VITAMIN B12 IN SERUM AND CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS.

W BASIL, J K BROWN, D M MATTHEWS.   

Abstract

There are several claims that B(12) concentrations in serum and cerebrospinal fluid are grossly abnormal in multiple sclerosis, but results are conflicting. This paper reports measurements of these concentrations in 40 serum samples and 23 samples of lumbar cerebrospinal fluid from cases of multiple sclerosis, and in appropriate controls, using Euglena gracilis, z strain. The serum concentrations were found to be normal; the mean concentration in cerebrospinal fluid was slightly reduced, but all values were within the control range. In both control samples and samples from cases of multiple sclerosis, the B(12) concentration in lumbar cerebrospinal fluid was correlated with the concentration in serum. There was no correlation between B(12) concentration and total protein in cerebrospinal fluid.A number of estimations of serum B(12) were also made with Lactobacillus leichmannii, after extraction in the presence and absence of cyanide. These showed a difference between cases of multiple sclerosis and controls, one interpretation of which might be that the serum in multiple sclerosis contains an abnormally low concentration of hydroxocobalamin.

Entities:  

Keywords:  BLOOD; BLOOD CHEMICAL ANALYSIS; CEREBROSPINAL FLUID; MULTIPLE SCLEROSIS; VITAMIN B 12

Mesh:

Substances:

Year:  1965        PMID: 14304244      PMCID: PMC472932          DOI: 10.1136/jcp.18.3.317

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  VITAMIN B 12 LEVELS IN THE SERUM AND CEREBROSPINAL FLUID IN MILTIPLE SCLEROSIS.

Authors:  C A SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-04       Impact factor: 10.154

2.  ISOLATION OF METHYLCOBALAMIN FROM NATURAL SOURCE MATERIAL.

Authors:  K LINDSTRAND
Journal:  Nature       Date:  1964-10-10       Impact factor: 49.962

3.  INVESTIGATIONS INTO THE EUGLENA METHOD FOR THE ASSAY OF THE VITAMIN B12 IN SERUM.

Authors:  B B ANDERSON
Journal:  J Clin Pathol       Date:  1964-01       Impact factor: 3.411

4.  Free and total vitamin B12 in cerebrospinal fluid.

Authors:  H M KIDD; C E GOULD; J W THOMAS
Journal:  Can Med Assoc J       Date:  1963-04-27       Impact factor: 8.262

5.  [Vitamin B 12 in spinal fluid in various diseases].

Authors:  F A GJERTSEN; A SCHRUMPF
Journal:  Nord Med       Date:  1962-02-01

6.  Calcium and vitamin B12 binding to proteins in human serum and cerebrospinal fluid. In vitro experiments.

Authors:  J CLAUSEN; T MUNKNER
Journal:  Acta Pathol Microbiol Scand       Date:  1962

7.  Blood serum levels and intestinal absorption of vitamin B12 in multiple sclerosis.

Authors:  V GRANN; G B GLASS
Journal:  J Lab Clin Med       Date:  1961-04

8.  Co60 Vit. B12 binding capacity of normal human cerebrospinal fluid.

Authors:  L M MEYER; R W BERTCHER; C MULZAC
Journal:  Proc Soc Exp Biol Med       Date:  1959-03

9.  Elevated vitamin levels in cerebrospinal fluid in multiple sclerosis.

Authors:  H SOBOTKA; N CHRISTOFF; H BAKER
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

10.  Vitamin B12 assay in body fluids.

Authors:  G I M ROSS
Journal:  Nature       Date:  1950-08-12       Impact factor: 49.962

View more
  3 in total

1.  Cyanide metabolism and vitamin B12 in multiple sclerosis.

Authors:  D M Matthews; J Wilson; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-10       Impact factor: 10.154

2.  Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia.

Authors:  T Q Nijst; R A Wevers; H C Schoonderwaldt; O R Hommes; A F de Haan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

3.  Alpha-amino nitrogen in cerebrospinal fluid and its alterations in meningitis, multiple sclerosis, and some other neurological disorders.

Authors:  E M Williams; D M Matthews
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.